Day One Biopharmaceuticals Inc (DAWN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 158,182 | 131,161 | 0 | 0 | 0 |
| Cost of Goods | 17,210 | 5,279 | N/A | N/A | N/A |
| Gross Profit | 140,972 | 125,882 | N/A | N/A | N/A |
| Operating Expenses | 268,932 | 343,431 | 206,064 | 146,909 | 72,743 |
| Operating Income | -127,750 | -217,270 | -206,064 | -146,909 | -72,743 |
| Other Income | 18,452 | 128,918 | 17,147 | 4,728 | -11 |
| Pre-tax Income | -109,298 | -88,352 | -188,917 | -142,181 | -72,754 |
| Income Tax | -1,976 | 7,144 | N/A | N/A | N/A |
| Net Income Continuous | -107,322 | -95,496 | -188,917 | -142,181 | -72,754 |
| Minority Interests | N/A | N/A | N/A | N/A | -2,109 |
| Net Income | $-107,322 | $-95,496 | $-188,917 | $-142,181 | $-70,645 |
| EPS Basic Total Ops | -1.04 | -1.02 | -2.37 | -2.17 | -4.62 |
| EPS Basic Continuous Ops | -1.04 | -1.02 | -2.37 | -2.17 | -1.97 |
| EPS Diluted Total Ops | -1.04 | -1.02 | -2.37 | -2.17 | -4.62 |
| EPS Diluted Continuous Ops | -1.04 | -1.02 | -2.37 | -2.17 | -1.97 |
| EPS Diluted Before Non-Recurring Items | -1.04 | -1.02 | -2.37 | -2.17 | -4.62 |
| EBITDA(a) | $-123,964 | $-215,241 | $-205,681 | $-146,378 | $-72,544 |